Clinical Trials in Los Angeles

Showing 13421-13440 of 16,901 trials

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

NCT00203424

The purpose of this study is to evaluate the safety and effectiveness of bevacizumab plus erlotinib following radical prostatectomy.

Prostate Cancer

Translational Oncology Research International23 participantsStarted Jan 2006

Alhambra, California, United States • Bakersfield, California, United States • Fullerton, California, United States +13 more locations

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

NCT01684163

GLYX-13 is a NMDA receptor glycine site partial agonist being studied in subjects with major depressive disorder (depression) who have responded inadequately to another antidepressant drug during the current episode. This trial will assess the effects of GLYX-13 on depression when added to another antidepressant drug that the patient is already taking.

Major Depressive Disorder

Naurex, Inc, an affiliate of Allergan plc369 participantsStarted Nov 2012

Birmingham, Alabama, United States • Encino, California, United States • Los Alamitos, California, United States +23 more locations

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Find Trials by Condition in Los Angeles

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Observational Study of Complications Related to Use of Peripherally Inserted Central Catheters

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole

Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia

Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).

Safety and Efficacy of EVT 101 in Treatment-Resistant Depression

APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)